Literature DB >> 1117064

Demonstration of insulin resistance in untreated adult onset diabetic subjects with fasting hyperglycemia.

H Ginsberg, G Kimmerling, J M Olefsky, G M Reaven.   

Abstract

We have used a continuous intravenous infusion of glucose (6 mg/kg/min), insulin (80 mU/min), epinephrine (6 mug/min), and propranolol (0.08 mg/min) to directly assess insulin resistance in 14 untreated adult onset diabetics with a mean (plus or minus SE) fasting plasma glucose level of 217 plus or minus 17 mg/100 ml. During the infusion endogenous insulin secretion is inhibited and steady-state plasma glucose and insulin levels are achieved after 90 min. Since similar steady-state levels of plasma insulin are achieved in all subjects, the plasma glucose concentration observed during the steady-state period is a measure of an individual's insulin resistance. Under these conditions, the mean (plus or minus SE) steady-state plasma glucose level of the 14 diabetic patients was 350 plus or minus 16 mg/100 ml, while that of 12 normal subjects was 121 plus or minus 4 mg/100 ml. Additional studies were performed in which control subjects and patients with diabetes had their fasting plasma glucose levels acutely raised or lowered to comparable levels before receiving the basic infusion mixture of glucose, insulin, epinephrine, and propranolol. The results of these studies indicated that differences in initial plasma glucose levels could not account for the different glucose responses of the two groups to the basic infusion. Finally, the mean (plus or minus SE) steady-state plasma glucose level of 104 plus or minus 17 mg/100 ml observed during the same basic infusion in five patients with fasting hyperglycemia (mean plus or minus SE, 142 plus or minus 12 mg/100 ml) secondary to chronic pancreatitis suggested that neither chronic hyperglycemia nor hypoinsulinemia per se necessarily lead to insulin resistance. These results demonstrate that marked insulin resistance exists in adult onset diabetics with fasting hyperglycemia. Since previous studies have documented the presence of insulin resistance in patients with chemical diabetes, the possibility exists that insulin resistance may be characteristic of adult onset diabetes mellitus.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1117064      PMCID: PMC301772          DOI: 10.1172/JCI107951

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  16 in total

1.  CRITICAL FACTORS IN EXCESSIVE SERUM-INSULIN RESPONSE TO GLUCOSE. OBESITY IN MATURITY-ONSET DIABETES AND GROWTH HORMONE IN ACROMEGALY.

Authors:  J H KARAM; G M GRODSKY; F C PAVLATOS; P H FORSHAM
Journal:  Lancet       Date:  1965-02-06       Impact factor: 79.321

2.  The glucose fatty-acid cycle. Its role in insulin sensitivity and the metabolic disturbances of diabetes mellitus.

Authors:  P J RANDLE; P B GARLAND; C N HALES; E A NEWSHOLME
Journal:  Lancet       Date:  1963-04-13       Impact factor: 79.321

3.  Plasma insulin concentrations in nondiabetic and early diabetic subjects. Determinations by a new sensitive immuno-assay technic.

Authors:  R S YALOW; S A BERSON
Journal:  Diabetes       Date:  1960 Jul-Aug       Impact factor: 9.461

4.  Serial postprandial plasma insulin levels in 117 subjects with and without diabetes.

Authors:  G Tchobroutsky; A Kopf; E Eschwege; R Assan
Journal:  Diabetes       Date:  1973-11       Impact factor: 9.461

5.  Insulin patterns in equivocal glucose tolerance tests (chemical diabetes).

Authors:  T S Danowski; R C Khurana; S Nolan; T Stephan; C G Gegick; S Chae; C Vidalon
Journal:  Diabetes       Date:  1973-11       Impact factor: 9.461

6.  Comparison of the effects of metabolic acidosis and acute uremia on carbohydrate tolerance.

Authors:  J Weisinger; R S Swenson; W Greene; J B Taylor; G M Reaven
Journal:  Diabetes       Date:  1972-11       Impact factor: 9.461

7.  Comparison of impedance to insulin-mediated glucose uptake in normal subjects and in subjects with latent diabetes.

Authors:  S W Shen; G M Reaven; J W Farquhar
Journal:  J Clin Invest       Date:  1970-12       Impact factor: 14.808

8.  The significance and interpretation of mildly abnormal oral glucose tolerance.

Authors:  F P Alford; F I Martin; M J Pearson
Journal:  Diabetologia       Date:  1971-06       Impact factor: 10.122

9.  Automated colorimetric determination of free fatty acids in biologic fluids.

Authors:  C Dalton; C Kowalski
Journal:  Clin Chem       Date:  1967-09       Impact factor: 8.327

10.  Studies of pancreatic alpha cell function in normal and diabetic subjects.

Authors:  R H Unger; E Aguilar-Parada; W A Müller; A M Eisentraut
Journal:  J Clin Invest       Date:  1970-04       Impact factor: 14.808

View more
  45 in total

Review 1.  Pathogenesis of impaired glucose tolerance and type II diabetes mellitus--current status.

Authors:  M B Davidson
Journal:  West J Med       Date:  1985-02

2.  Effects of insulin on peripheral and splanchnic glucose metabolism in noninsulin-dependent (type II) diabetes mellitus.

Authors:  R A DeFronzo; R Gunnarsson; O Björkman; M Olsson; J Wahren
Journal:  J Clin Invest       Date:  1985-07       Impact factor: 14.808

3.  Lipid metabolism by muscle of diabetic rats.

Authors:  M B Davidson; R G Karjala
Journal:  Acta Diabetol Lat       Date:  1979 Apr-Jun

Review 4.  The metabolic syndrome: time for a critical appraisal. Joint statement from the American Diabetes Association and the European Association for the Study of Diabetes.

Authors:  R Kahn; J Buse; E Ferrannini; M Stern
Journal:  Diabetologia       Date:  2005-09       Impact factor: 10.122

5.  Relationship between body fat mass, carbohydrate tolerance and IRI response during glucose infusion in subjects with early diabetes.

Authors:  K P Ratzmann; S Knospe; P Heinke; B Schulz
Journal:  Acta Diabetol Lat       Date:  1979 Jan-Mar

6.  Blood pressure lowering by pioglitazone. Evidence for a direct vascular effect.

Authors:  T A Buchanan; W P Meehan; Y Y Jeng; D Yang; T M Chan; J L Nadler; S Scott; R K Rude; W A Hsueh
Journal:  J Clin Invest       Date:  1995-07       Impact factor: 14.808

7.  Effect of islet activating protein on glucose tolerance, insulin secretion and insulin responsiveness in the NZO mouse.

Authors:  C A Re; M C Veroni; R G Larkins
Journal:  Diabetologia       Date:  1984-04       Impact factor: 10.122

8.  Differential roles of splanchnic and peripheral tissues in the pathogenesis of impaired glucose tolerance.

Authors:  L Saccà; G Orofino; A Petrone; C Vigorito
Journal:  J Clin Invest       Date:  1984-06       Impact factor: 14.808

9.  Evaluation of insulin resistance during inhibition of endogenous insulin and glucagon secretion by somatostatin in non-obese subjects with impaired glucose tolerance.

Authors:  K P Ratzmann; W Besch; S Witt; B Schulz
Journal:  Diabetologia       Date:  1981-09       Impact factor: 10.122

10.  Insulin secretion and insulin sensitivity defects are a common feature of mild, clinically homogeneous, recently diagnosed type II (non-insulin-dependent) diabetics.

Authors:  E Pisu; A Lombardi; D De Benedictis; C Bozzo; E Chiara; C Baggiore; A Bruno; L Cravero; G Pagano; G Lenti
Journal:  Acta Diabetol Lat       Date:  1986 Jul-Sep
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.